1. Home
  2. DAWN vs COUR Comparison

DAWN vs COUR Comparison

Compare DAWN & COUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$21.20

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Coursera Inc.

COUR

Coursera Inc.

HOLD

Current Price

$6.16

Market Cap

1.0B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAWN
COUR
Founded
2018
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
DAWN
COUR
Price
$21.20
$6.16
Analyst Decision
Strong Buy
Buy
Analyst Count
9
14
Target Price
$27.11
$11.07
AVG Volume (30 Days)
2.3M
6.0M
Earning Date
05-25-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
39.22
EPS
N/A
N/A
Revenue
$158,182,000.00
$757,500,000.00
Revenue This Year
$53.52
$9.10
Revenue Next Year
$27.10
$6.38
P/E Ratio
N/A
N/A
Revenue Growth
20.60
9.04
52 Week Low
$5.64
$5.47
52 Week High
$13.20
$13.56

Technical Indicators

Market Signals
Indicator
DAWN
COUR
Relative Strength Index (RSI) 82.69 45.62
Support Level $6.40 $5.47
Resistance Level N/A $6.38
Average True Range (ATR) 0.77 0.31
MACD 0.65 0.04
Stochastic Oscillator 99.73 32.85

Price Performance

Historical Comparison
DAWN
COUR

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

About COUR Coursera Inc.

Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through three reporting segments: Consumer, Enterprise, and Degrees. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.

Share on Social Networks: